US to Resume J&J COVID Vaccinations Despite Rare Clot RiskUS to Resume J&J COVID Vaccinations Despite Rare Clot RiskAdvisers to the Centers for Disease Control and Prevention said Friday the benefits of the single-dose COVID-19 shot outweigh a rare risk of blood clots.Associated PressAssociated Press